Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III TWIN Program for the Treatment of Acne Vulgaris

Stock Information for Sol-Gel Technologies Ltd.

Loading

Please wait while we load your information from QuoteMedia.